548 Odcinki

  1. Fighting for Other People's Children

    Opublikowany: 18.09.2019
  2. A Doctor's Quest to Cure His Own Rare Disease

    Opublikowany: 11.09.2019
  3. Susannah Cahalan and her Month of Madness

    Opublikowany: 4.09.2019
  4. The Benefits Support Groups Offer Rare Disease Patients

    Opublikowany: 29.08.2019
  5. Targeting the Epigenetic Drivers of Cancer

    Opublikowany: 21.08.2019
  6. Tackling Kidney Diseases with Orally-Delivered Enzymes

    Opublikowany: 14.08.2019
  7. Giving Voice to Patients through Data

    Opublikowany: 8.08.2019
  8. Seeking to Halt and Reverse Fibrotic Diseases

    Opublikowany: 31.07.2019
  9. Addressing the Complexities of Rare Disease with Centers of Excellence

    Opublikowany: 24.07.2019
  10. Using Cell Therapies to Restore Power in Mitochondrial Diseases

    Opublikowany: 17.07.2019
  11. Passage Bio Betting on Penn Connection to Give It an Edge in Developing Gene Therapies

    Opublikowany: 10.07.2019
  12. Finding Appropriate Endpoints and Measures for Rare Eye Diseases

    Opublikowany: 3.07.2019
  13. Marrying Antibodies and Oligonucleotides to Target Genetic Medicine

    Opublikowany: 26.06.2019
  14. What Rare Disease Patients Should Understand about Genetics

    Opublikowany: 19.06.2019
  15. Program Seeks to Drive Collaborative Research Model Among Rare Disease Groups

    Opublikowany: 12.06.2019
  16. A Gene Hunter Becomes a Drug Hunter Too

    Opublikowany: 5.06.2019
  17. The Psychological Toll Rare Diseases Can Have on Healthy Siblings

    Opublikowany: 29.05.2019
  18. Blood Test Can Provide Earlier Diagnosis of Autism Spectrum Disorder

    Opublikowany: 22.05.2019
  19. Understanding the Role of Natural History Studies in Clinical Trials

    Opublikowany: 15.05.2019
  20. How Two Mothers Discovered That a Drug for One Rare Disorder Might Benefit Another

    Opublikowany: 8.05.2019

16 / 28

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Visit the podcast's native language site